Prader-Willi Syndrome Clinical Trials

145 clinical trials for Prader-Willi Syndrome across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome — RECRUITING
• Parent and Infant Inter(X)Action Intervention (PIXI) — RECRUITING · NA
• The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics — RECRUITING · NA
• Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation — RECRUITING · NA
• A Study of CSTI-500 in Patients With Prader-Willi Syndrome — RECRUITING · PHASE2
• Impact of Bright Light Therapy on Prader-Willi Syndrome — RECRUITING · NA
• A Study of Pitolisant in Participants With Prader-Willi Syndrome — RECRUITING · PHASE3
• A Study of Pitolisant in Patients With Prader-Willi Syndrome — RECRUITING · PHASE3
• Physical Activity and Community EmPOWERment Project — RECRUITING · NA
• IDMet (RaDiCo Cohort) (RaDiCo-IDMet) — RECRUITING
• Institutional Registry of Rare Diseases — RECRUITING
• A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment — RECRUITING · PHASE1
• Cerebellar TMS and Satiety in Prader-Willi Syndrome — RECRUITING · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ARD-101 FOR THE TREATMENT OF HYPERPHAGIA IN PATIENTS WITH PRADER -WILLI SYNDROME — RECRUITING · PHASE3
• Tirzepatide in PWS, HO and GNSO — RECRUITING · PHASE4
• Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome — RECRUITING
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF PITOLISANT FOLLOWED BY AN OPEN-LABEL EXTENSION IN PATIENTS WITH PRADERWILLI SYNDROME — RECRUITING · PHASE3
• Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome — RECRUITING · NA
• Register of Patients With Prader-Willi Syndrome — RECRUITING
• GROWing Up With Rare GENEtic Syndromes — RECRUITING
• Intranasal administration of oxytocin in children with Prader-Willi Syndrome — NOT_YET_RECRUITING · PHASE3
• A Phase IIa study to evaluate the safety, tolerability, and effects of AZP-531 on food-related behavior in patients with Prader-Willi Syndrome — COMPLETED · PHASE2
• Early Check: Expanded Screening in Newborns — ACTIVE_NOT_RECRUITING
• The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial — TERMINATED · PHASE3
• ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial — TERMINATED · PHASE3
• A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension — COMPLETED · PHASE2
• CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) — TERMINATED · PHASE2
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome — TERMINATED · PHASE3
• PWS European Blood Bank for Infants and Controls From 0 to 48 Months — COMPLETED · NA
• A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS — ACTIVE_NOT_RECRUITING · PHASE3
• A Study of Setmelanotide in Patients With Prader-Willi Syndrome — ACTIVE_NOT_RECRUITING · PHASE2
• Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS — COMPLETED · PHASE3
• Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome — COMPLETED · PHASE2
• A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome. — NOT_YET_RECRUITING · PHASE2
• Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic Education — COMPLETED · NA
• Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome — COMPLETED · PHASE4
• Brain Olfactory Pathways in Prader-Willi Syndrome — NOT_YET_RECRUITING · NA
• A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome — COMPLETED · PHASE2
• Evaluation of the Psychological Profile of Adult Patients With Prader-Willi Syndrome — COMPLETED
• Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome — ACTIVE_NOT_RECRUITING · PHASE3
• Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact — COMPLETED
• Respiratory Restriction in Prader-Willi Syndrome — COMPLETED
• Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome — COMPLETED · PHASE2
• LONG-TERM INTERVENTIONAL FOLLOW-UP STUDY UP TO 4 YEARS OF AGE OF CHILDREN WITH PRADER-WILLI SYNDROME INCLUDED IN THE OTBB3 CLINICAL TRIAL AND COMPARISON WITH AN UNTREATED COHORT OF CHILDREN WITH PRADER-WILLI SYNDROME (OTBB3 FOLLOW-UP) — OTHER · PHASE2
• An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) — WITHDRAWN · PHASE2
• PWS Outcomes Assessment Study — COMPLETED
• Ultrasound to Assess Sarcopenia in Prader Willi Syndrome — COMPLETED
• Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS) — ACTIVE_NOT_RECRUITING
• Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome — COMPLETED · PHASE4
• Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome — COMPLETED · PHASE2

Refine this search